You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 5, 2026

Cellulose sodium phosphate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for cellulose sodium phosphate and what is the scope of freedom to operate?

Cellulose sodium phosphate is the generic ingredient in one branded drug marketed by Mission Pharma and is included in one NDA. Additional information is available in the individual branded drug profile pages.

Summary for cellulose sodium phosphate
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
DailyMed Link:cellulose sodium phosphate at DailyMed

US Patents and Regulatory Information for cellulose sodium phosphate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mission Pharma CALCIBIND cellulose sodium phosphate POWDER;ORAL 018757-003 Oct 16, 1984 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Mission Pharma CALCIBIND cellulose sodium phosphate POWDER;ORAL 018757-002 Dec 28, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Market Dynamics and Financial Trajectory for Cellulose Sodium Phosphate

Last updated: February 21, 2026

What is the Global Market Size and Growth Rate for Cellulose Sodium Phosphate?

Cellulose sodium phosphate (CSP) is primarily utilized as a food additive, pharmaceutical excipient, and in industrial applications, such as water treatment. The global market size was valued at approximately $80 million in 2022 and is projected to grow at a compound annual growth rate (CAGR) of about 5.2% through 2030.

Key factors influencing growth include increasing demand for high-quality food additives, rising pharmaceutical R&D expenditures, and expanding industrial applications. Market reports indicate a steady upward trend driven by regulatory approvals and innovation in food safety and drug formulation sectors.

What Are the Key Drivers and Restraints Impacting Market Trajectory?

Drivers

  • Food Industry Demand: CSP functions as a stabilizer and emulsifier. Rising consumer focus on food safety and clean-label products fosters growth.
  • Pharmaceutical Applications: CSP serves as a binder and disintegrant, supporting drug formulation advancements. Expansion in generic drug manufacturing boosts demand.
  • Industrial Uses: Growing investments in water treatment facilities utilize CSP for phosphate removal, especially in emerging markets.

Restraints

  • Regulatory Restrictions: Stringent regulations in certain regions restrict use or impose higher compliance costs. Notable examples include the EU’s food additive regulations.
  • Raw Material Variability: Quality fluctuations in cellulose sources impact production consistency and costs.
  • Environmental Concerns: Disposal and environmental impact related to phosphates impose additional compliance and innovation costs.

Who Are the Major Market Participants?

Market players include multinational chemical companies, specialty additive producers, and pharmaceutical excipient suppliers.

Company Market Share (Estimated, 2022) Primary Focus
FMC Corporation 30% Pharmaceutical excipients, food additives
DuPont 20% Water treatment, industrial applications
Ashland Global Holdings 15% Food stabilization, pharmaceutical ingredients
Others 35% Regional and niche suppliers

These firms invest in R&D to develop CSP variants with enhanced solubility, stability, and environmental profiles.

What Are the Key Trends and Innovation Pathways?

  • Product Diversification: Development of CSP derivatives with improved bioavailability and stability.
  • Green Manufacturing: Adoption of eco-friendly extraction and synthesis processes to meet environmental standards.
  • Regulatory Navigation: Strategies to align with global and regional safety standards, facilitating broader market access.

How Do Pricing and Revenue Models Evolve?

Pricing for CSP fluctuates based on raw material costs, regulatory compliance expenses, and application-specific quality demands.

Year Average Price (USD/kg) Notes
2020 $12 Baseline before notable raw material cost increases
2022 $15 Price escalation driven by supply chain disruptions and increased demand
2025 Projection $18 Anticipated stabilization with efficiencies in manufacturing

Revenue is generated through direct sales to food and pharmaceutical manufacturers, with emphasis on customized formulations for large clients. Margins remain modest, around 15-20%, due to competitive pressures.

What Are the Future Investment and R&D Opportunities?

Emerging R&D focuses on bio-based CSP, reducing reliance on conventional cellulose sources, and improving environmental profiles. Investment in process automation and advanced purification techniques aims to lower production costs.

Markets in Asia-Pacific and Latin America show substantial growth potential, with increased industrialization and regulatory easing. Companies that innovate in product quality and compliance stand to capture higher market share.

Conclusions

The CSP market displays predictable growth influenced by food, pharmaceutical, and industrial sectors. The key financial trajectory involves moderate revenue increases, driven by expanded application scope and technological innovation. Companies leveraging sustainability initiatives and regulatory alignment are positioned for competitive advantage.

Key Takeaways

  • Market size was approximately $80 million in 2022, growing at 5.2% CAGR through 2030.
  • Major applications include food additives, pharmaceuticals, and water treatment.
  • Leading players hold an estimated 65% combined market share.
  • Price per kilogram increased from $12 in 2020 to around $15 in 2022.
  • Innovation in green production and product customization offers growth avenues.

FAQs

1. What factors are most critical for CSP market expansion?
Growth depends on increased demand in food safety, pharmaceutical formulations, and environmental applications, supported by regulatory acceptance and innovation.

2. How do regulatory policies influence market dynamics?
Strict regulations in regions like the EU necessitate compliance investments, which can slow growth but also create barriers for less compliant competitors.

3. Which regions exhibit the highest growth potential?
Asia-Pacific and Latin America are emerging markets, driven by industrialization, urbanization, and regulatory improvements.

4. What are the primary challenges facing CSP producers?
Raw material variability, environmental compliance costs, and regulatory restrictions pose significant hurdles.

5. What technological innovations could impact future CSP pricing?
Bio-based manufacturing methods, streamlined purification processes, and environmentally friendly synthesis reduce costs and improve market competitiveness.


References

[1] Market Research Future. (2023). Global Cellulose Sodium Phosphate Market Analysis.
[2] Grand View Research. (2023). Food Additives and Pharmaceutical Excipients Market Overview.
[3] European Food Safety Authority. (2022). Regulatory Policies on Food Additives.
[4] Global Water Treatment Market. (2022). Industrial Use of Phosphates in Water Treatment.
[5] Bloomberg Industry Group. (2023). Chemical Industry Reports.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.